International Day for the Evaluation of Abdominal obesity: Rationale and design of a primary care study on the prevalence of abdominal obesity and associated factors in 63 countries

European Heart Journal, Supplement

Volumn 8, Issue B, 2006, Pages

  Wittchen, Hans Ulrich ^a   Balkau, Beverley ^b   Massien, Christine ^c   Richard, Alain ^c   Haffner, Steven ^d   Després, Jean Pierre ^e  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b INSERM   (France)

^c SANOFI   (France)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

Abdominal obesity; Coronary heart disease; Epidemiology; Prevalence; Primary care; Waist circumference

Indexed keywords

ABDOMINAL OBESITY; COMORBIDITY; CONFERENCE PAPER; DISEASE ASSOCIATION; DYSLIPIDEMIA; EPIDEMIOLOGICAL DATA; EVALUATION; GENERAL PRACTICE; HUMAN; HYPERTENSION; INTERNATIONAL COOPERATION; INTERNATIONAL DAY FOR THE EVALUATION OF ABDOMINAL OBESITY; ISCHEMIC HEART DISEASE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT PARTICIPATION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS; WAIST CIRCUMFERENCE;

EID: 33749006233     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sul005     Document Type: Conference Paper

References (34)

1. Haffner SM. Obesity and the metabolic syndrome: the San Antonio Heart Study. Br J Nutr 2000;83(Suppl. 1):S67-S70.
2. Haffner SM. Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation. Int J Obes Relat Metab Disord 2000;24(Suppl. 2):S56-S58.
3. Poirier P, Eckel RH. Obesity and cardiovascular disease. Curr Atheroscler Rep 2002;4:448-453.
4. Hoefle G, Saely CH, Aczel S, Benzer W, Marte T, Langer P, Drexel H. Impact of total and central obesity on vascular mortality in patients undergoing coronary angiography. Int J Obes Relat Metab Disord 2005;29:785-791.
5. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, Willett WC, Manson JE. Abdominal adiposity and coronary heart disease in women. JAMA 1999;281:2284-2285.
6. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952.
7. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 1997;145:614-619.
8. Han TS, Williams K, Sattar N, Hunt KJ, Lean MEJ, Haffner SM. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res 2002;10:923-931.
9. Bertrais S, Balkau B, Vol S, Forhan A, Calvet C, Marre M, Eschwege E. Relationships between abdominal body fat distribution and cardiovascular risk factors: an explanation for women's healthier cardiovascular risk profile. The D.E.S.I.R. Study. Int J Obes Relat Metab Disord 1999;23:1085-1094.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). JAMA 2001;285:2486-2497.
11. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.
12. Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-1062.
13. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004;27:2444-2449.
14. Jorgensen ME, Glumer C, Bjerregaard P, Gyntelberg F, Jorgensen T, Borch-Johnsen K. Obesity and central fat pattern among Greenland Inuit and a general population of Denmark (Inter99): relationship to metabolic risk factors. Int J Obes 2003;27:1507-1515.
15. Moreau M, Valente F, Mak R, Pelfrene E, de Smet P, De Backer G, Kornitzer M. Obesity, body fat distribution and incidence of sick leave in the Belgian workforce: the Belstress study. Int J Obes 2004,28:574-582.
16. Balkau B, Vernay M, Mhamdi L, Novak M, Arondel D, Vol S, Tichet J, Eschwege E. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab 2003;29:526-532.
17. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, Gabriel R, Williams K, Gomez-Gerique JA, Stern MP, Haffner SM. Central adiposity determines prevalence differences of the metabolic syndrome. Obes Res 2003;11:1480-1487.
18. Erem C, Arslan C, Hacihasanoglu A, Deger O, Topbas M, Ukinc K, Ersoz HO, Telatar M. Prevalence of obesity and associated risk factors in a Turkish population (Trabzon City, Turkey). Obes Res 2004;12:1117-1127.
19. Wittchen HU, Glaesmer H, Marz W, Stalla G, Lehnert H, Zeiher AM, Silber S, Koch U, Bohler S, Pittrow D, Ruf G. Cardiovascular risk factors in primary care: methods and baseline prevalence rates-the DETECT program. Curr Med Res Opin 2005;21:619-630.
20. Park HS, Oh SW, Cho SI, Choi WH, Kim YS. The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol 2004;33:328-336.
21. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004;27:1182-1186.
22. Jia WP, Xiang KS, Lu JX, Wu YM. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev 2002;3:157-165.
23. Fezeu L, Minkoulou E, Balkau B, Kengne A-P, Awah P, Unwin N, Alberti GKMM, Mbanya J-C. Association between socioeconomic status and adiposity in urban Cameroon. Int J Epidemiol 2006;35:105-111.
24. Godfrey R, Julien M. Urbanisation and health. Clin Med 2005;5:137-141.
25. Vorster HH. The emergence of cardiovascular disease during urbanisation of Africans. Public Health Nutr 2002;5:239-243.
26. Galal OM. The nutrition transition in Egypt: obesity, undernutrition and the food consumption context. Public Health Nutr 2002;5:141-148.
27. Zimmet P, Arblaster M, Thoma K. The effect of westernization on native populations. Studies on a Micronesian community with a high diabetes prevalence. Aust NZJ Med 1978;8:141-146.
28. Bentley D, Floyd R. A sample of brilliance. Comm Assoc Comput Mach 1987;30:754-757.
29. Bentley AL, Knuth D. Literate programming. Comm Assoc Comput Mach 1986;29:364-369.
30. Regional Office for the Western Pacific (WPRO), World Health Organization, International Association for the Study of Obesity, International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment (2000). www.diabetes.com.au/pdf/obesity_report.pdf (November 2005).
31. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-949.
32. Ferroni P, Basili S, Falco A, Davi G. Inflammation, insulin resistance, and obesity. Curr Atheroscler Rep 2004;6:424-431.
33. Lebovitz HE. The relationship of obesity to the metabolic syndrome. Int J Clin Pract Suppl 2003;33:18-27.
34. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Despres JP. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000;102:179-184.